Dr. Alexander Daniel Zanotto, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-0063 |
Joseph M. Lasnier, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Smith Ave N, Suite 300, Saint Paul, MN 55102 Phone: 651-726-6200 |
Dr. Jonathan David Shelver, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-3456 Fax: 651-254-9673 |
Linda M. Funk, M.D. Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 225 Smith Ave N, Suite 300, Saint Paul, MN 55102 Phone: 651-726-6200 |
Jeffery R Dichter, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 849 Govern Circle, Saint Paul, MN 55123 Phone: 651-271-4463 |
Anuja Sharma, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Smith Ave N Ste 501, Saint Paul, MN 55102 Phone: 651-726-6200 Fax: 651-726-6201 |
Gabriel Nicolas Guzman, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-0063 Fax: 651-254-5535 |
Rwoof Ahmed Reshi, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 Smith Ave N Ste 440, Saint Paul, MN 55102 Phone: 651-241-6550 Fax: 651-241-6586 |
News Archive
Here's a bold prediction for the new year. By 2020, the American health insurance industry will be extinct. Insurance companies will be replaced by accountable care organizations -; groups of doctors, hospitals and other health care providers who come together to provide the full range of medical care for patients.
Regeneron Pharmaceuticals, Inc. and Zoetis Inc. today announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments.
Takeda Pharmaceutical Company Limited today announced the completion of the study to fulfill the post-marketing commitment and submissions of data to regulatory authorities from the Pan European Multi-Database Bladder Cancer Risk Characterization Study, a large (n= 112,674), multi-database retrospective matched cohort study, conducted in four European countries, for pioglitazone containing medicines, including ACTOS with up to 10 years of follow-up.
A meta-analysis of 10 studies suggests that receipt of a blood transfusion among patients with myocardial infarction (heart attack) was associated with increased all-cause mortality compared with not receiving a blood transfusion during heart attack, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
› Verified 3 days ago